title: Osteoporosis.
abstract: Osteoporosis is a skeletal disorder characterized by compromised bone strength that predisposes a person to increased risk of fracture. Fractures have severe consequences, so fracture prevention is imperative. Risk factor assessment and bone density testing are important tools in the diagnosis of osteoporosis. Actions to promote strong bones include adequate intakes of calcium and vitamin D; being physically active; not smoking; and avoiding excessive alcohol use. There are several FDA-approved medications for the treatment of osteoporosis. The recent attention to osteonecrosis of the jaw (ONJ) and the association between dental and skeletal health speak to the importance of osteoporosis awareness for dental professionals.
authors.affiliation: nievesj@helenhayeshosp.org
authors.forename: Jeri W
authors.initials: JW
authors.lastname: Nieves
authors.forename: Michelle
authors.initials: M
authors.lastname: Mosner
authors.forename: Shari
authors.initials: S
authors.lastname: Silverstein
mesh_terms: D015502:Absorptiometry, Photon; D000368:Aged; D045930:Anabolic Agents / Q000627:therapeutic use; D059266:Bisphosphonate-Associated Osteonecrosis of the Jaw; D050071:Bone Density Conservation Agents / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D050723:Fractures, Bone / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009909:Oral Health; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy / Q000473:pathology; D019379:Teriparatide / Q000627:therapeutic use
chemical_list: D045930:Anabolic Agents; D050071:Bone Density Conservation Agents; D019379:Teriparatide